Integrated clinicopathological model versus TNM for predicting survival in resected hepatocellular carcinoma: a retrospective cohort study
Authors:
- Gia Anh PhamGia Anh Pham
- Trung Nghia BuiTBTrung Nghia Bui
- Tien Cong BuiTBTien Cong Bui
- Manh Thau CaoMCManh Thau Cao
- Hong Son TrinhHTHong Son Trinh
- Thi Huyen Trang VoTVThi Huyen Trang Vo
- Thanh Tung PhamTPThanh Tung Pham
- Thi Thu Hang NguyenTNThi Thu Hang Nguyen
- Thanh Lam PhanTPThanh Lam Phan
- Thu Hang NongTNThu Hang Nong
- Thi Ngoc TranTTThi Ngoc Tran
Open Access
- 7 May 2026
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26
Abstract
Objective: To explore prognostic factors of postoperative hepatocellular carcinoma (HCC) and compare the prognostic performance of the tumor–node–metastasis (TNM) system with an integrated clinicopathological model. Methods: We conducted a cohort study evaluating 249 patients with HCC who underwent radical liver resection between January 2015 and December 2024. Overall survival (OS) was the primary endpoint. Independent prognostic factors were determined using the Cox proportional hazards model. Model performance was assessed using the correlation index (C-index) with bootstrap internal validation. Time-dependent receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration plots were used to assess discrimination, clinical utility, and agreement between predicted and observed outcomes. Results: In multivariable analysis, TNM stage, microvascular invasion (MVI), resection margin status, and albumin–bilirubin (ALBI) grade were independent predictors of OS. For recurrence-free survival (RFS), independent predictors included hepatitis status, ALBI grade, TNM stage, and MVI. The integrated model demonstrated improved discrimination compared with TNM alone, with a higher optimism-corrected C-index (0.676 vs. 0.647). Time-dependent ROC analysis showed significantly higher AUC values for the integrated model at 1 year (0.725 vs. 0.669, p = 0.046), 3 years (0.703 vs. 0.657, p = 0.024), and 5 years (0.684 vs. 0.649, p = 0.031). DCA indicated greater net benefit across clinically relevant thresholds, and calibration plots showed good agreement between predicted and observed survival probabilities. Conclusion: An integrated clinicopathological model incorporating TNM stage, MVI, ALBI grade, and resection margin status improves prognostic performance compared with TNM alone in patients undergoing curative resection for HCC. This model may support more accurate postoperative risk stratification.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional studyHPB, 2019
- A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resectionClinica Chimica Acta, 2018
- Perioperative and prognostic implication of albumin‐bilirubin‐TNM score in Child‐Pugh class A hepatocellular carcinomaAnnals of Gastroenterological Surgery, 2018
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- Effectiveness of the albumin-bilirubin score as a prognostic factor for early recurrence after curative hepatic resection for hepatocellular carcinomaAnnals of Hepato-Biliary-Pancreatic Surgery, 2018
- Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinomaWorld Journal of Surgical Oncology, 2017
- Actual 10-Year Survivors After Resection of Hepatocellular CarcinomaAnnals of Surgical Oncology, 2016
- Prognostic value of the albumin–bilirubin grade in patients with hepatocellular carcinoma: Validation in a Chinese cohortHepatology Research, 2016
- Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: A comparative studyWorld Journal of Gastroenterology, 2010
- Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological FactorsAnnals of Surgical Oncology, 2008